**Background:** Life expectancy is rising in sub-Saharan Africa, yet the burden of age-related musculoskeletal diseases like osteoporosis and sarcopenia in this region is poorly understood. HIV infection, which is highly prevalent in Southern Africa, may exacerbate bone and muscle loss through chronic inflammation, ART effects, and nutritional deficiencies. This study aimed to determine the prevalence of osteoporosis and sarcopenia in a rural South African community with high HIV prevalence and to investigate associations between HIV, BMD, muscle strength, lean mass, and gait speed.
**Methods:** This cross-sectional study was nested within a wider multimorbidity study in the Agincourt Health and Socio-Demographic Surveillance System site in Bushbuckridge, Mpumalanga province, South Africa. Participants aged 20–80 years were recruited through household sampling (phase 1–2) and word-of-mouth (phase 3) between November 2017 and November 2018. Data collection included questionnaires, anthropometry, HIV testing, grip strength (hand dynamometry), maximal gait speed over 6 meters, and DXA (Hologic Discovery A) for BMD and body composition. Sarcopenia was defined per EWGSOP2 guidelines: probable sarcopenia (low grip strength: <16 kg women, <27 kg men), confirmed (plus low ALM/height²: <5.5 kg/m² women, <7.0 kg/m² men), severe (plus gait speed ≤0.8 m/s). Osteoporosis was defined as BMD T-score ≤ -2.5 at any site for those aged ≥50 years, using NHANES III white reference data. Linear and logistic regression were used to assess associations, with multivariable models adjusting for age, sex, grip strength, ALM/height², gait speed, fat mass, and HIV status.
**Key Results:** Among 805 participants (mean age 44.6 ± 14.8 years; 68.2% female; all black South African), HIV prevalence was 13.2% in men and 23.6% in women, with 88% on ART. Osteoporosis prevalence in those aged ≥50 years was: femoral neck 19.4% in women (95% CI 14.2–25.6) and 4.2% in men (95% CI 1.2–10.4); lumbar spine 18.4% in women (95% CI 13.3–24.5) and 8.4% in men (95% CI 3.7–15.9); total hip 5.0% in women (95% CI 2.4–9.0) and 3.2% in men (95% CI 0.7–9.0). Femoral neck osteoporosis was significantly more common in women with HIV than without (37.1% vs 15.7%; p=0.003). HIV infection was associated with approximately 0.5 SD lower femoral neck BMD in both sexes. No participant had confirmed or severe sarcopenia; probable sarcopenia affected 11.6% of men and 4.4% of women (p=0.001), with no association with HIV. In multivariable analysis, older age, female sex, lower ALM/height², slower gait speed, and HIV infection were independently associated with lower femoral neck BMD. An age-by-HIV interaction was found for total body less head BMD in women (interaction p=0.027), suggesting greater postmenopausal bone loss in those with HIV.
**Clinical Implications:** Osteoporosis is a substantial and under-recognized problem in rural South Africa, particularly among older women living with HIV, where 37% had femoral neck osteoporosis. Despite high obesity rates (73% of women overweight/obese), no participants reported use of osteoporosis medications. Sarcopenia was rare, possibly due to obesity masking lean mass deficits or inappropriate European cut-points. The strong independent associations between muscle measures and BMD suggest muscle-strengthening interventions could benefit bone health. The findings support integrating routine bone health assessment into HIV care for aging women in South Africa, especially given the availability of the South African FRAX tool. However, osteoporosis treatment remains limited as medications are not on the Essential Drugs List. Limitations include cross-sectional design, lack of ART duration/type data, use of non-African reference data for BMD T-scores, and potential selection bias toward healthier participants.